- Lobbying
- Lobbying by Human Longevity, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Matthew Johnson | Counsel/Chief Counsel, Sen. John Cornyn |
Binta Beard | Health Legislative Assistant, Sen. Dick Durbin |
Nora Connors | Legislative Assistant, Sen. Dianne Feinstein |
Amy Pellegrino | Senior Health Policy Adviser, Sen. Olympia Snowe / Legislative Assistant, Rep. Rob Simmons |
Josh Holly | Communications Director/Spokesman/Staff, House Armed Services Committee / Director of Media Affairs, House Education & Workforce Committee / Press Secretary, Rep. Ernie Fletcher |
Israel Klein | Deputy Staff Director/Communications, Joint Economic Committee / Press Secretary/Legislative Assistant/Senior Communications Adviser, Rep. Ed Markey / Communications Director, Sen. Charles Schumer |
Oscar Ramirez | Special Assistant to the Secretary, Department of Labor / Chief of Staff, Rep. Hilda Solis / Legislative Director/Deputy Chief of Staff, Rep. Al Green / Legislative Assistant/Assistant Legislative Director/LD, Rep. Joe Baca |
James Dyer | Staff Director, House Appropriations Committee |
Jessica Lawrence-Vaca | Legislative Aide/Legislative Assistant/Sr. Policy Adviser, Rep. Albio Sires // Legislative Correspondent, Sen. Patty Murray // Staff Assistant/Legislative Correspondent, Rep. Steve Rothman |
David Morgenstern | Legislative Director/Chief of Staff, Sen. Lamar Alexander // Legislative Assistant/Counsel, Sen. Lincoln Chafee Legislative Director/Chief of Staff, Sen. Lamar Alexander // Legislative Assistant/Counsel, Sen. Lincoln Chafee |
Anthony Podesta | n/a |
Beth Inadomi | n/a |
Anna Weinstein | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Executive Office of the President (EOP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Executive Office of the President (EOP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Executive Office of the President (EOP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Executive Office of the President (EOP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Healthcare and biotechnology.
NIH and FDA funding.
Genomic medicine and computing..
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Science & Technology Policy (OSTP)
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate